Pharmafile Logo
Pharmafocus logo
Advanced Search

Phoenix Cardiac gains CE Mark for “game-changer” MR device

April 26, 2021
Sales and Marketing CE Mark, EU, cardiovascular

Phoenix Cardiac Devices have received CE Mark certification for its BACE (basal annuloplasty of the cardia externally) device, a novel …

News
Top 10 news roundup

Phamafile.com’s top 10 news stories of the week

April 23, 2021
Medical Communications COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma, pharma news

Among our top 10 stories this week: A study has found the Pfizer COVID-19 vaccine to have a significantly reduced …

News

Researchers find possible new treatment for several cancers

April 23, 2021
Medical Communications Cancer, The Institute of Cancer Research, cancer treatment, kidney cancer treatment, pharma, pharma news

Researchers at The Institute of Cancer Research (ICR) in London have discovered a new use for an ovarian and breast …

News
lonza

Lonza to invest over £150 million on new molecule complex

April 23, 2021
Medical Communications Lonza

Lonza have announced the construction of a new small molecule manufacturing complex at its Visp site in Switzerland, which will …

News
img_4190-e1376666350337-web

MHRA gives green light to new cardiovascular treatment

April 23, 2021
Medical Communications MHRA, cardiovascular

The MHRA has granted a Great Britain Marketing Authorisation for Vazkepa (icosapent ethyl) as a treatment to reduce the risk …

News
az

AstraZeneca drug evaluated in nine eosinophilic diseases

April 23, 2021
Medical Communications AstraZeneca

AstraZeneca announced on Thursday that the first patients had been dosed in the Phase III Fasenra (benralizumab) clinical trial in …

News
Lab testing

Lipidor to begin Phase III trial on psoriasis treatment

April 22, 2021
Phase III trials, lipidor, pharma, pharma news, psoriasis

Lipidor has submitted an application with the Indian Medical Products Agency to begin a Phase III trial on their drug …

News

Novo Nordisk to expand obesity study into oral treatment

April 22, 2021
Novo Nordisk, obesity

Novo Nordisk is planning to initiate a Phase IIIa study of oral semaglutide in obesity, expanding on its Phase IIIa …

News

Jubilant’s oral remdesivir formulation shows positive results in human trial

April 22, 2021
COVID-19, Gilead, Jubilant Pharma, covid-19 treatment, pharma, pharma news, remdesivir

Jubilant Pharma has announced the successful completion of studies in human volunteers for their oral formulation of remdesivir – an …

News

UK Company launches COVID-19 neutralisation assay development kit

April 22, 2021
COVID-19

The Native Antigen Company, a supplier of reagents for research into diagnostics and vaccines, have announced the launch of its …

News

Bharat Biotech jab shows 100% efficacy against severe COVID-19

April 22, 2021
COVID-19, India

Indian biopharma company, Bharat Biotech, has reported interim analysis results from the Phase III trial of its COVID-19 vaccine, Covaxin, …

News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 21, 2021
Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news

The past week has seen lots of COVID-19 developments; Avacta’s 20-minute COVID test has gained clinical validation, the EMA has …

News
Amgen flag

Amgen stomach cancer drug awarded Breakthrough Therapy Designation

April 21, 2021
Research and Development Amgen, Cancer, cancer treatment, pharma, pharma news

Amgen’s investigational therapy, bemarituzumab, for certain types of stomach and esophagus cancer, has been granted Breakthrough Therapy Designation by the …

News

J&J COVID-19 vaccine to resume Europe rollout

April 21, 2021
Research and Development COVID-19, COVID-19 vaccine, J&J, J&J vaccine, JJ, pharma, pharma news

The Johnson & Johnson COVID-19 vaccine will continue its rollout in Europe, following a review from the EMA.

News

GW Pharma’s cannabidiol gains EC approval

April 21, 2021
Research and Development EC, EU, cannabis

GW Pharmaceuticals has received European Commission (EC) approval for the type II variation application for Epidyolex (cannabidiol), as an adjunctive …

News

UK Government launches COVID-19 Antivirals Taskforce

April 21, 2021
Research and Development COVID-19, UK government

A new Antivirals Taskforce has been launched by the government to identify treatments for UK patients who have been exposed …

News

Adagio raises $336 million to advance COVID-19 antibody

April 20, 2021
Manufacturing and Production Adagio, COVID-19, Financing, covid-19 treatment, pharma, pharma news

Adagio Therapeutics has financed $336 million to support the rapid advancement of their novel ADG20 antibody for the treatment and …

News

Oxford University & Prenetics to collaborate on global rapid testing tech

April 20, 2021
Manufacturing and Production

The University of Oxford, Prenetics Limited and the Oxford Suzhou Centre for Advanced Research (OSCAR) have signed collaboration agreements to …

News
credit_-_crevis_shutterstock_340710245_720

Enhertu now available via Cancer Drugs Fund following NICE decision

April 20, 2021
Manufacturing and Production AstraZeneca, breast cancer, oncology

AstraZeneca and Daiichi Sankyo have announced that NICE has approved Enhertu (trastuzumab deruxtecan) for use within the Cancer Drugs Fund …

News

Novartis multiple sclerosis treatment recommended by NICE

April 20, 2021
Manufacturing and Production NICE, Novartis, multiple sclerosis, pharma, pharma news

NICE have recommenced Novartis’ ofatumumab (Kesimpta) for the treatment of relapsing remitting MS (RRMS) in adult patients for use on …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025